Home » Newsletters » BioWorld Science

BioWorld Science

May 26, 2008

View Archived Issues

Improved in vitro profile and therapeutic index with Pfizer's new bronchodilator UK-503590

Targeting the GPR4 receptor shows benefit in models of lung injury and COPD

Johnson & Johnson new LTA4H inhibitor reduces allergic airways inflammation in vivo

ST-2472 exhbits potent antipsychotic effects and good safety profile in vivo

Antitumor effects of chemotherapy enhanced by inhibition of N-cadherin

Novel mechanism for benzodiazepine receptor ligand PK-11195 identified

Medivir reports new therapeutic options for HCV infection in recent patent

Recent patents describe novel treatment alternatives for eye disorders

Recent patents disclose novel anti-HIV agents

Recent patents impart novel treatment options for cancer

DOR BioPharma withdraws E.U. MAA for orBec and plans phase III study

Allon completes dosing in phase II AL-208 cognitive impairment trial

FDA issues approvable letter for bazedoxifene in postmenopausal osteoporosis

GTx phase III toremifene trial continues after interim efficacy analysis

Novo Nordisk files for regulatory approval of liraglutide in the U.S. and Europe

ProStrakan grants exclusive license to JapanBridge for Sancuso in parts of Asia

Panobinostat active against poorly differentiated and anaplastic thyroid carcinoma cells

First patients enrolled in switch trial of oral iclaprim

Synthetic Blood International obtains exclusive license to VCU discoveries

Draxis Health acquisition approved by shareholders

First MS therapeutic from Novartis approved for launch in Europe

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...